Open AccessEfficacy of 5% permethrin-2% fusidic acid cream compared to 5% permethrin-placebo in the treatment of impetiginized scabies
Author(s) -
Aninda Marina,
Sri Linuwih Menaldi,
Endi Novianto,
Sandra Widaty
Publication year - 2022
Publication title -
journal of infection in developing countries
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.322
H-Index - 49
eISSN - 2036-6590
pISSN - 1972-2680
DOI - 10.3855/jidc.15205
Subject(s) - permethrin , fusidic acid , scabies , medicine , placebo , dermatology , staphylococcus aureus , antibiotics , microbiology and biotechnology , bacteria , biology , genetics , alternative medicine , pathology , pesticide , agronomy
Scabies is caused by Sarcoptes scabiei var hominis, often causing secondary bacterial infections, especially by Streptococcus pyogenes and Staphylococcus aureus. Permethrin 5% cream is the first-line of treatment that is recommended, combined with Fusidic acid 2% cream as the first-line topical antibiotic. We investigated the efficacy of a combination of permethrin 5% cream and fusidic acid 2% cream for the treatment of impetiginized scabies.